CoChat

MPC1 deficiency accelerates lung adenocarcinoma progression through the STAT3 pathway

Open access
Zou, Hongbo, Chen, Qian, Zhang, Anmei, Wang, Songtao, Wu, Hong, Yuan, Ye, Wang, Shuang, Yu, Jing, Luo, Mao, Wen, Xianmei, Cui, Wei, Fu, Wenjuan, Yu, Ruilian, Chen, Lin, Zhang, Ming, Lan, Haitao, Zhang, Xia, Xie, Qichao, Jin, Guoxiang, Xu, Chuan · 2019 · Cell Death & Disease
Cited by 35

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Abstract

Mitochondrial pyruvate carrier 1 (MPC1), a key factor that controls pyruvate transportation in the mitochondria, is known to be frequently dysregulated in tumor initiation and progression. However, the clinical relevance and potential molecular mechanisms of MPC1 in lung adenocarcinoma (LAC) progression remain to be illustrated. Herein, MPC1 was lowly expressed in LAC tissues and significantly associated with favorable survival of patients with LAC. Functionally, MPC1 markedly suppressed stemness, invasion, and migration in vitro and spreading growth of LAC cells in vivo. Further study revealed that MPC1 could interact with mitochondrial signal transducer and activator of transcription 3 (mito-STAT3), disrupting the distribution of STAT3 and reducing cytoplasmic signal transducer and activator of transcription 3 (cyto-STAT3) as well as its phosphorylation, while the activation of cyto-STAT3 by IL-6 reversed the attenuated malignant progression in MPC1-overexpression LAC cells. Collectively, we reveal that MPC1/STAT3 axis plays an important role in the progression of LAC, and our work may promote the development of new therapeutic strategies for LAC.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41419-019-1324-8

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Cited by

See all 35

Metadata

Authors
Zou, H., Chen, Q., Zhang, A., Wang, S., Wu, H., Yuan, Y., Wang, S., Yu, J., Luo, M., Wen, X., Cui, W., Fu, W., Yu, R., Chen, L., Zhang, M., Lan, H., Zhang, X., Xie, Q., Jin, G., & Xu, C.
Venue
Cell Death & Disease
Published
2019-02-15
Volume
10
Issue
3
Pages
148-148
ISSN
2041-4889 (ISSN-L)
OpenAlex
W2913677780
Cited by
35
References
8
FWCI
1.90
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: MPC1 deficiency accelerates lung adenocarcinoma progression through the STAT3 pathway. https://app.cochat.ai/papers/10.1038/s41419-019-1324-8
The paper
Zou, H., Chen, Q., Zhang, A., Wang, S., Wu, H., Yuan, Y., Wang, S., Yu, J., Luo, M., Wen, X., Cui, W., Fu, W., Yu, R., Chen, L., Zhang, M., Lan, H., Zhang, X., Xie, Q., Jin, G., & Xu, C. (2019). MPC1 deficiency accelerates lung adenocarcinoma progression through the STAT3 pathway. Cell Death & Disease. https://doi.org/10.1038/s41419-019-1324-8

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.